Last Price$37.29.3%
Market Cap$3,309.7M
LTM Goodwill & Intangible Assets
$175.5M
YoY Growth
+25.3%
3Y CAGR
+218.5%
5Y CAGR
N/A
Stock quality & Intrinsic value
6/10
83.7% undervalued
Legend Biotech Corporation Goodwill & Intangible Assets
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|
| Goodwill & Intangible Assets | $2,000.0 | $49.0K | $5,149.0K | $2,852.0K | $4,684.0K | $3,409.0K | $4,061.0K |
Overvalued or undervalued?
Check the intrinsic value for LEGN
and see if it's the right time to invest.
Legend Biotech Corporation (LEGN) Goodwill & Intangible Assets comparison analysis
General
LTM Goodwill & Intangible Assets
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Legend Biotech CorporationLEGN
$175.5M
25.3%
218.5%
N/A
Median Peer Set
$82.9M
(1.8%)
0.0%
0.0%
Vertex Pharmaceuticals IncorporatedVRTX
$1,913.9M
(0.7%)
10.9%
6.4%
BioNTech SEBNTX
$1,212.6M
(5.8%)
79.5%
67.3%
Regeneron Pharmaceuticals, Inc.REGN
$1,148.6M
10.6%
N/A
N/A
BioMarin Pharmaceutical Inc.BMRN
$451.5M
(8.0%)
(8.3%)
(7.1%)
United Therapeutics CorporationUTHR
$111.9M
(2.0%)
35.9%
(6.7%)
BeiGene, Ltd.BGNE
$53.9M
0.5%
56.0%
53.7%
Summit Therapeutics Inc.SMMT
$1,864.0K
(1.5%)
(46.8%)
(26.8%)
Royalty Pharma plcRPRX
$0.0
(100.0%)
(100.0%)
(100.0%)
Alnylam Pharmaceuticals, Inc.ALNY
$0.0
(100.0%)
N/A
N/A
argenx SEARGX
N/A
N/A
N/A
N/A
LEGN key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|
% growth | 23.6 0.0% | 49.1 108.2% | 57.3 16.5% | 75.7 32.2% | 89.8 18.7% | 117.0 30.3% | 285.1 143.7% |
| Cost of Goods Sold (COGS) | (0.1) | 0.0 | 0.0 | 232.2 | 313.3 | 65.4 | 144.2 |
% margin | 23.7 100.4% | 49.1 100.0% | 57.3 100.0% | (156.5) (206.8%) | (223.6) (249.0%) | 51.6 44.1% | 140.9 49.4% |
| Operating Expenses | 9.6 | 64.2 | 192.6 | 304.9 | 462.8 | 509.7 | 140.9 |
| Research & Development Expenses (R&D) | 8.2 | 60.6 | 161.9 | 232.2 | 313.3 | 335.6 | 382.2 |
| Selling, General & Administrative Expenses (SG&A) | 1.4 | 3.9 | 32.4 | 72.7 | 149.5 | 174.0 | 200.9 |
% margin | 13.8 58.4% | (1.5) (3.1%) | (130.9) (228.5%) | (313.3) (414.1%) | (393.0) (437.7%) | (455.8) (389.6%) | (439.5) (154.1%) |
| Interest Income | 0.0 | 6.2 | 4.6 | 2.9 | 1.0 | 8.2 | 54.5 |
| Interest Expense | 0.0 | 0.1 | 0.2 | 4.2 | 0.9 | 10.8 | 21.8 |
| Pre-tax Income | 13.8 | (1.6) | (130.4) | (307.6) | (386.2) | (445.7) | (520.1) |
% effective tax rate | 4.5 32.3% | 1.2 (72.3%) | 2.6 (2.0%) | (4.1) 1.3% | 0.0 (0.0%) | 0.6 (0.1%) | (1.9) 0.4% |
% margin | 9.4 39.7% | (2.8) (5.7%) | (133.0) (232.2%) | (303.5) (401.0%) | (386.2) (430.1%) | (446.3) (381.5%) | (518.3) (181.8%) |
| EPS | 0.07 | (0.03) | (1.01) | (2.57) | (2.74) | (2.81) | (2.94) |
| Diluted EPS | 0.07 | (0.03) | (1.01) | (2.57) | (2.74) | (2.81) | (2.94) |
% margin | 14.1 59.6% | 0.1 0.3% | (124.9) (218.1%) | (294.1) (388.7%) | (392.4) (437.0%) | (416.5) (356.0%) | (477.9) (167.6%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Legend Biotech Corporation's Goodwill & Intangible Assets?
As of today, Legend Biotech Corporation's last 12-month Goodwill & Intangible Assets is $175.5M, based on the financial report for Sep 30, 2024 (Q3’2024).
2) What is Legend Biotech Corporation's Goodwill & Intangible Assets growth rate?
Over the last year, Legend Biotech Corporation's Goodwill & Intangible Assets growth was 25.3%. The average annual Goodwill & Intangible Assets growth rates for Legend Biotech Corporation have been 250.3% over the past three years, N/A over the past five years.